Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Pazopanib and Ixabepilone in Patients With Solid Tumors

NCT01012362 is registered in ClinicalTrials.gov with Masonic Cancer Center, University of Minnesota as lead sponsor.

NCT NCT01012362
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01012362 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Pazopanib and Ixabepilone in Patients With Solid Tumors
Lead sponsor
Masonic Cancer Center, University of Minnesota
Phase
Phase 1
Overall status
Terminated
Start date
December 31, 2009
Completion date
February 28, 2013
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, colon cancer, head and neck cancer, hepatocellular cancer, kidney cancer, lung cancer, pancreatic cancer, sarcoma